Norcantharidin b

CAS No. 29745-04-8

Norcantharidin b( Endothall anhydride )

Catalog No. M20338 CAS No. 29745-04-8

Norcantharidin is a synthetic anticancer compound which is a dual inhibitor for c-Met and EGFR in human colon cancers.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 48 In Stock
25MG 67 In Stock
50MG 100 In Stock
100MG 145 In Stock
200MG Get Quote In Stock
500MG 356 In Stock
1G 528 In Stock

Biological Information

  • Product Name
    Norcantharidin b
  • Note
    Research use only, not for human use.
  • Brief Description
    Norcantharidin is a synthetic anticancer compound which is a dual inhibitor for c-Met and EGFR in human colon cancers.
  • Description
    Norcantharidin is a synthetic anticancer compound which is a dual inhibitor for c-Met and EGFR in human colon cancers.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Endothall anhydride
  • Pathway
    Angiogenesis
  • Target
    c-Met/HGFR
  • Recptor
    EGFRc-Met
  • Research Area
    Cancer
  • Indication
    Cancer

Chemical Information

  • CAS Number
    29745-04-8
  • Formula Weight
    168.15
  • Molecular Formula
    C8H8O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:33 mg/mL (196.25 mM)
  • SMILES
    [H][C@@]12[C@H]3CC[C@H](O3)[C@]1([H])C(=O)OC2=O
  • Chemical Name
    47-Epoxyisobenzofuran-13-dione hexahydro- (3a-alpha4-beta7-beta7a-alpha)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Qiu P Wang S Liu M et al. Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells[J]. BMC Cancer 2017 17(1):55.
molnova catalog
related products
  • Onartuzumab

    Onartuzumab (MetMAb) is a humanized anti-tyrosine kinase c-MET monovalent monoclonal antibody.

  • Capmatinib hydrochlo...

    Capmatinib hydrochloride is a potent orally active selective and ATP competitive c-Met kinase inhibitor?potently blocking in vitro kinase activity (IC50 = 0.13 nM) as well as constitutive or HGF-stimulated activity in cells (IC50 values range from 0.3 to 1.1 nM).

  • JNJ-38877605

    JNJ-38877605 is a potent, selective, ATP-competitive inhibitor of catalytic activity c-Met with IC50 of 4 nM.